Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab

被引：38

作者：

Hongeng, S

Tardtong, P

Worapongpaiboon, S

Ungkanont, A

Jootar, S

机构：

[1] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok 10400, Thailand

[2] Mahidol Univ, Ramathibodi Hosp, Dept Pathol, Bangkok 10400, Thailand

[3] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Internal Med, Bangkok 10400, Thailand

来源：

BONE MARROW TRANSPLANTATION | 2002年 / 29卷 / 10期

关键词：

unrelated bone marrow transplantation; autoimmune haemolytic anaemia; rituximab;

D O I：

10.1038/sj.bmt.1703551

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

Here, we report a case of paediatric beta-thalassaemia major patient who underwent unrelated T cell-non-depleted bone marrow transplantation and developed a complication of autoimmune haemolytic anaemia (AIHA) refractory to corticosteroid and intravenous immunoglobulin therapy. After this child received two doses (375 mg/m(2)/dose) of rituximab (anti-CD20 monoclonal antibody), his AIHA was resolved.

引用

页码：871 / 872

页数：2

共 5 条

[1] Ahrens N, 2001, BRIT J HAEMATOL, V114, P244
[2] Drobyski WR, 1996, BONE MARROW TRANSPL, V17, P1093
[3] Rituximab chimeric Anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma:: Half of patients respond to a four-dose treatment program
McLaughlin, P
Grillo-López, AJ
Link, BK
Levy, R
Czuczman, MS
Williams, ME
Heyman, MR
Bence-Bruckler, I
White, CA
Cabanillas, F
Jain, V
Ho, AD
Lister, J
Wey, K
Shen, D
Dallaire, BK
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2825 - 2833
[4] Treatment of childhood autoimmune haemolytic anaemia with rituximab
Quartier, P
Brethon, B
Philippet, P
Landman-Parker, J
Le Deist, F
Fischer, A
[J]. LANCET, 2001, 358 (9292) : 1511 - 1513
[5] Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia
Zecca, M
De Stefano, P
Nobili, B
Locatelli, F
[J]. BLOOD, 2001, 97 (12) : 3995 - 3997

← 1 →